Pablo J. Cagnoni, Director: Rubius Therapeutics RUBY Sell · Filed 23/02/01

Trade details

Type: Insider sale
Amount: $2,112
Shares · price: 8,448 sh · $0.25 a share
Held after: 66,082 sh
Stock: Rubius Therapeutics RUBY
Person: Pablo J. CagnoniDirector
Trade date: 23/02/01
Filed: 23/02/01
Days to filing: 0 days

Sold 11.3% of holdings

Share of holding sold: 11.3%

Rubius Therapeutics trades, last 26 weeks

What else happened in Rubius Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/02~23/03/03

Pablo J. Cagnoni's recent trades

Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$2.8M
23,218 sh
$2.8M
Filed 09/15
Traded 09/15
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.4M
10,801 sh
$1.4M
Filed 08/19
Traded 08/19
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.3M
10,803 sh
$1.3M
Filed 08/12
Traded 08/12
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.3M
10,640 sh
$1.3M
Filed 08/05
Traded 08/05
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.9M
15,888 sh
$1.9M
Filed 07/31
Traded 07/31

Pablo J. Cagnoni, Director — sold $2,112 of Rubius Therapeutics RUBY · 11.3% of holdings | Whalegun